Status:

NOT_YET_RECRUITING

Combined Exercise and PMS: Impact on Biopsychosocial Function in Older Adults With Schizophrenia

Lead Sponsor:

Yuntong Zhang

Conditions:

Schizophrenia Patients

Eligibility:

All Genders

60-80 years

Phase:

NA

Brief Summary

This project consists of two randomized parallel - group experiments targeting older adults with schizophrenia, aiming to evaluate the therapeutic effect of Peripheral Magnetic Stimulation (PMS). Exp...

Detailed Description

Project Experimental Protocol (Revised Version) This project consists of two randomized parallel-group experiments involving older adults with schizophrenia, aiming to evaluate the therapeutic effects...

Eligibility Criteria

Inclusion

  • \# Eligibility Criteria
  • Participants must be aged ≥60 years.
  • Diagnosis of schizophrenia based on the International Classification of Diseases - 10th Edition (ICD-10) or Diagnostic and Statistical Manual of Mental Disorders - 5th Edition (DSM-5).
  • Diagnosis must be made for ≥6 months, with clinical manifestations of schizophrenia (e.g., hallucinations, delusions, thought disorder, etc.).
  • No history of severe acute psychiatric episodes or hospitalizations within the last 3 months prior to enrollment.
  • Symptoms must be controllable, with no reliance on acute psychiatric intervention.
  • Participants must be able to understand the study's purpose and procedures and provide written informed consent. If the participant is unable to provide full informed consent (e.g., due to severe cognitive impairment), informed consent must be obtained from a legal guardian.

Exclusion

  • Schizoaffective disorder or bipolar disorder with psychosis.
  • Elderly individuals with multiple chronic diseases but who still maintain good functional status and quality of life.
  • Presence of severe cardiovascular diseases, liver or kidney dysfunction, cerebrovascular diseases, or other physical conditions that may affect treatment.
  • Patients with contraindications to peripheral magnetic stimulation (PMS) treatment or EEG.

Key Trial Info

Start Date :

September 28 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 5 2025

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT07194460

Start Date

September 28 2025

End Date

December 5 2025

Last Update

September 26 2025

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.